GFM
ETON icon

GF Fund Management’s Eton Pharmaceutcials ETON Stock Holding History

GF Fund Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.6K Sell
569
-28
-5% -$821 ﹤0.01% 479
2026
Q1 		$14.7K Buy
597
+70
+13% +$1.22K ﹤0.01% 526
2025
Q4 		$8.91K Buy
+527
New +$9.27K ﹤0.01% 583

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

GF Fund Management's ETON Position: Q2 2026 in Review

GF Fund Management reduced its Eton Pharmaceutcials (ETON) stake by 4.7% in Q2 2026, selling an estimated $821 and leaving 569 shares worth $20.6K. The position accounts for ﹤0.01% of the portfolio, ranked #479.

GF Fund Management first reported a position in ETON in Q4 2025 and has held it in 3 quarters since. 165 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • GF Fund Management held 569 shares of Eton Pharmaceutcials worth $20.6K as of Q2 2026.
  • GF Fund Management sold 28 Eton Pharmaceutcials shares in Q2 2026, an estimated $821.
  • Eton Pharmaceutcials made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #479 holding.
  • GF Fund Management first reported a position in Eton Pharmaceutcials in Q4 2025 and has held it in 3 quarters since.
  • 165 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.